Prazepam and Risperdal drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Prazepam (prazepam) and Risperdal (risperidone). Common drug interactions include anxiety among females and drug abuse among males.

The phase IV clinical study analyzes what interactions people have when they take Prazepam and Risperdal. It is created by eHealthMe based on reports of 89 people who take the same drugs from the FDA, and is updated regularly.

What is Prazepam?

Prazepam has active ingredients of prazepam. eHealthMe is studying from 3,173 Prazepam users. Check the latest studies of Prazepam.

What is Risperdal?

Risperdal has active ingredients of risperidone. It is often used in bipolar disorder. eHealthMe is studying from 127,729 Risperdal users. Check the latest studies of Risperdal.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

89 people who take Prazepam and Risperdal together, and have interactions are studied.

Prazepam and Risperdal drug interactions.

What are the common drug interactions of Prazepam and Risperdal, by gender? *:

female:

Anxiety
Aspartate aminotransferase increased
Attention deficit/hyperactivity disorder
Bronchopneumopathy
C-reactive protein increased
Cervical vertebral fracture
Clonic convulsion (long lasting seizure)
Communication disorder (speech and language disorder)
Cough
Delusion (a false belief or opinion)

male:

Drug abuse
Coma (state of unconsciousness lasting more than six hours)
Hypokinesia (decreased bodily movement)
Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents)
Overdose
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
Thrombocytopenia (decrease of platelets in blood)
Depressed level of consciousness
Hypovolaemic shock (shock caused by severe blood or fluid loss)
Leukopenia (less number of white blood cells in blood)

What are the common drug interactions of Prazepam and Risperdal, by age (0-1 to 60+)? *:

0-1:

Agitation (state of anxiety or nervous excitement)
Cerebral atrophy (decrement in size of brain)
Complications of maternal exposure to therapeutic drugs
Developmental coordination disorder
Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
Dyskinesia neonatal (abnormality or impairment of voluntary movement-in child)
Dystonia (abnormal muscle tone)
Eye movement disorder
Hypertonia (abnormal increase in muscle tension and a reduced ability of a muscle to stretch)
Hypotonia neonatal (low muscle tone in neonatal)

2-9:

n/a

10-19:

Aggression
Drug abuse
Hyperhidrosis (abnormally increased sweating)
Hypokinesia (decreased bodily movement)
Somnolence (a state of near-sleep, a strong desire for sleep)
Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents)

20-29:

Drug abuse
Coma (state of unconsciousness lasting more than six hours)
Hypoventilation (too shallow or too slow breathing, which does not meet the needs of the body)
Hypovolaemia (a decreased volume of circulating blood in the body)
Miosis (constriction of the pupil of the eye, resulting from a normal response to an increase in light)
Overdose
Depressed level of consciousness
Hypovolaemic shock (shock caused by severe blood or fluid loss)
Loss of consciousness
Mydriasis (a dilation of the pupil)

30-39:

Pneumonia
Leukopenia (less number of white blood cells in blood)
Drug ineffective
Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents)

40-49:

Bladder dilatation
Lung disorder (lung disease)
Myopericarditis (disease caused by inflammation of the myocardium (muscle of the heart wall) and/or the pericardium)
Psychomotor skills impaired
Quadriparesis (muscle weakness affecting all four limbs)
Urinary retention (the inability to completely or partially empty the bladder)
Delusion of reference
Intentional self-injury
Suicidal ideation
Trismus (reduced opening of the jaws)

50-59:

Intestinal obstruction
Dysphagia (a condition in which swallowing is difficult or painful)
Self injurious behaviour
Sluggishness (lacking alertness)
Sopor (sleep)
Abnormal behaviour
Agitation (state of anxiety or nervous excitement)
Attention deficit/hyperactivity disorder
Bradycardia (abnormally slow heart action)
Communication disorder (speech and language disorder)

60+:

Somnolence (a state of near-sleep, a strong desire for sleep)
Balance disorder
Incoherent (talking in a confused and unclear way)
Overdose
Septic shock (shock due to blood infection)
Coma (state of unconsciousness lasting more than six hours)
Confusional state
Cerebral atrophy (decrement in size of brain)
Dyskinesia oesophageal (abnormality or impairment of voluntary movement of oesophageal)
Fatigue (feeling of tiredness)

What are the existing conditions these people have? *

Stress And Anxiety: 22 people, 24.72%
Psychotic Disorder: 20 people, 22.47%
Depression: 17 people, 19.10%
Insomnia (sleeplessness): 15 people, 16.85%
Agitation (state of anxiety or nervous excitement): 11 people, 12.36%
Diarrhea: 7 people, 7.87%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 6 people, 6.74%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 6 people, 6.74%
Personality Disorder: 5 people, 5.62%

* Approximation only. Some reports may have incomplete information.

Do you take Prazepam and Risperdal?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously